Eric Sievers - 29 Nov 2021 Form 4 Insider Report for BioAtla, Inc. (BCAB)

Role
Chief Medical Officer
Signature
/s/ Christian Vasquez, as Attorney-in-Fact for Eric Sievers
Issuer symbol
BCAB
Transactions as of
29 Nov 2021
Transactions value $
-$2,628
Form type
4
Filing time
06 Dec 2021, 19:41:53 UTC
Previous filing
30 Nov 2021
Next filing
07 Dec 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BCAB Common Stock Sale -$2,627 -110 -0.12% $23.89* 92,630 29 Nov 2021 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of the Issuer's common stock sold by the reporting person to cover taxes due upon the release and settlement of the vested RSUs.
F2 The range of prices for the shares of Common Stock is from $23.75 to $24.11. The reporting person undertakes that he will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities sold at each separate price.